| Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients V Ruiz-Carpio, P Sandoval, A Aguilera, P Albar-Vizcaíno, ... Scientific reports 7 (1), 44941, 2017 | 36 | 2017 |
| Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer MA Zaballos, A Acuña-Ruiz, M Morante, P Crespo, P Santisteban Endocrine-related cancer 26 (6), R319-R344, 2019 | 31 | 2019 |
| Genomic and epigenomic profile of thyroid cancer A Acuña-Ruiz, C Carrasco-López, P Santisteban Best Practice & Research Clinical Endocrinology & Metabolism 37 (1), 101656, 2023 | 13 | 2023 |
| Yap governs a lineage-specific neuregulin1 pathway-driven adaptive resistance to RAF kinase inhibitors MER Garcia-Rendueles, G Krishnamoorthy, M Saqcena, A Acuña-Ruiz, ... Molecular Cancer 21 (1), 213, 2022 | 11 | 2022 |
| Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor J Ramírez-Moya, L Wert-Lamas, A Acuña-Ruíz, A Fletcher, ... Scientific Reports 12 (1), 7706, 2022 | 6 | 2022 |
| Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer MA Zaballos, A Acuña-Ruiz, M Morante, G Riesco-Eizaguirre, P Crespo, ... Cellular and Molecular Life Sciences 79 (9), 504, 2022 | 4 | 2022 |
| Role of SIX1 homeoprotein in the regulation of TGFβ pathway in anaplastic thyroid cancer A Acuna-Ruiz, G Riesco-Eizaguirre, P Santisteban 7th ESE Young Endocrinologists and Scientists (EYES) Meeting 67, 2019 | | 2019 |
| In vivo inhibition of microrna to decrease tumor growth in mice J Ramirez-Moya, L Wert-Lamas, A Acuña-Ruiz, MA Zaballos, ... JoVE (Journal of Visualized Experiments), e59322, 2019 | | 2019 |
| Antitumor activity of the ERK inhibitor DEL22379 against BRAF-like cells in thyroid cancer A Acuña-Ruiz, MA Zaballos, G Riesco-Eizaguirre, P Crespo, ... | | 2019 |
| Targeting RAS-ERK pathway an insight into scaffold proteins in thyroid cancer M Morante, R García-Gómez, A Acuña-Ruiz, MA Zaballos, ... | | 2018 |
| ERK dimers inhibition is a therapeutic target in thyroid cancer A Acuña-Ruiz, MA Zaballos, G Riesco-Eizaguirre, P Crespo, ... Problemy Endokrinologii 62 (5), 2016 | | 2016 |
| Inhibition of ERK dimerization blocks thyroid tumor progression M Zaballos, A Acuña-Ruiz, G Riesco-Eizaguirre, P Crespo, P Santisteban European Thyroid Journal 5, 2016 | | 2016 |
